Becker's Healthcare February 16, 2024
The FDA has approved omalizumab, which goes by the brand name Xolair, as a treatment to reduce the risk of severe allergic reactions for those with food allergies.
The drug, a prescription biologic medicine given as an injection under the skin, was approved as a treatment to cut the risk of allergic reactions that may occur among people age 1 and older with IgE-mediated food allergies, which are the most common type.
The drug is not intended to to be used as an emergency treatment of allergic reactions, and people taking the drug should continue to avoid foods...
Today's Sponsors
Today's Sponsor